Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 3 2021

Full Issue

Perspectives: Police Officers Could Save Lives If They Carried Narcan

Read recent commentaries about drug-cost issues.

The Berkshire Eagle: First Responders Should Be Carrying Narcan

Holistically addressing the addiction crisis is a big and complex task, but there is something relatively simple that can be done to save lives and protect first responders throughout the commonwealth. The state should mandate that all first responders carry Narcan. More than ever, our first responders are frequently heading to overdose calls. How we equip that response should be informed by the ongoing toll of the opioid epidemic. Narcan, the brand name of naloxone, is an opioid antagonist that can immediately reverse an opioid-related overdose. It is portable and simple to use, so it can be easily administered at the scene of a suspected overdose and save a victim from respiratory distress and possible death. (10/28)

The Tennessean: First-Hand Account By Witness Who Created Solutions For Tennessee Opioid Case

“Of all the gin joints in all the towns in the world," it happens that the first jury trial in the deluge of the opioid epidemic happened in northeast Tennessee. Three district attorneys representing nine northeast Tennessee counties ravaged by the opioid epidemic determined to prosecute three pharmaceutical companies. In early July 2022, the jury selection of six local Tennessean “peers” had begun. This was a litigation with three initial defendants, Purdue, Mallinckrodt and Endo Pharmaceuticals. (Lloyd I. Sederer, 10/31)

Los Angeles Times: How Supply And Demand Have Driven The U.S. Drug Crisis Into The 'Synthetic Era' 

At a party in Venice in September, four people overdosed from what they thought was cocaine, three of them dying before paramedics arrived. The cocaine they used reportedly contained fentanyl. The deaths were another example of what has taken place across the U.S. over the last few years as we have entered what I call the synthetic era of drugs — street dope made with chemicals; no plants involved. Synthetic drugs of various kinds have been around for decades, but none have come close to the supply and threat of the two staples now coming up from Mexico: fentanyl and methamphetamine. And with synthetic drugs, as with most other products both legal and illegal, supply shapes demand. (Sam Quinones, 10/31)

Santa Fe New Mexican: New Mexico Needs To Ensure More Affordable Prescription Drugs

Despite massive spending on lobbying and campaign contributions, the big drug companies are slowly losing their stranglehold on state legislatures across the country. In Maryland, Maine, Oregon and Colorado, consumers, patients, public health advocates and providers demanding more affordable prescription drugs have succeeded in passing landmark legislation that will finally help manage runaway drug costs. The New Mexico Legislature should build on this momentum and pass a Prescription Drug Affordability Board next session to help reduce the cost of health care and benefit all New Mexicans. (Jeff Steinborn and Angelica Rubio, 10/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF